Phylogenetic Analysis of Clinical and Environmental Aspergillus Fumigatus Isolates in Azerbaijan

Eco-epidemiological study of azole-resistant Aspergillus fumigatus in Somme department -France

v

Sophie Hartuis (FR)

2024

12

n/a

Discovery of a novel second mechanism of action of the triazole antifungals against Aspergillus fumigatus

v

Jeffrey Rybak (US)

2024

11

n/a

Uncovering the molecular basis of cell membrane integrity in azole-susceptible and azole-resistant isolates of Aspergillus fumigatus

v

Martin Weichert (NL)

2024

10

n/a

Characteristics of the individual SNPs and combinations thereof impact the azole phenotype in TR34-mediated resistance genotypes

v

Yinggain Song (CN)

2024

9

n/a

Spatial analysis to evaluate environmental factors related to Aspergillus fumigatus azole resistance in the Netherlands

v

Massimo Cogliati1, Jochem Buil2, Maria Carmela Esposto1, Anna Prigitano1, Luisa Romanò1, Paul Verweij2, Willem Melchers2

2024

8

n/a

Antifungal susceptibility of clinically significant Mucorales against amphotericin, posaconazole and isavuconazole from Pakistan

v

Kauser Jabeen (PK)

2024

7

n/a

Pioneering preclinical models to study mixed triazole-susceptible and triazole-resistant Aspergillus fumigatus infections

v

Agustin Resendiz Sharpe (BE)

2024

6

n/a

Overexpression of Efflux Pump Genes is an Alternative Mechanism in Voriconazole Resistant Aspergillus fumigatus isolates without Relative Mutations in cyp51A

v

Ms Pooja Sen (IN)

2024

5

n/a

Cyp51A gene mutations and azole resistance in clinical and environmental isolates of Aspergillus flavus from Pakistan

v

Professor Kauser Jabeen (PK)

2024

4

n/a

Rapid and stable adaptation to voriconazole of environmental Aspergillus fumigatus strains

v

Saioa Cendon-Sanchez (ES)

2024

n/a